An article from Bloomberg.com discusses Ban on a Common Acne…

Diane 35 is suspended from pharmacy counters after decades of use in France

(PRWeb February 13, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10414846.htm

Connect to BiotechBlog using social media

I would like to take this opportunity to invite you to connect on Social Media and to foster greater collaboration.

Connect on LinkedIn

Connecting on LinkedIn allows us to share networks. In addition to managing BiotechBlogy, I am also publisher of DrugPatentWatch.com and Chief Editor of the Journal of Commercial Biotechnology, so my network is broad and deep. Please feel free to contact me at any time with networking or other commercial requests.

Join the BiotechBlog group on Linkedin

This group focuses on the biotech industry. The audience and focus are the same as for BiotechBlog.com: Professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with the current issues and industry trends.

Follow @DrugPatentWatch on Twitter

This twitter feed publishes BiotechBlog updates, as well as the BiotechBlog Daily, a comprehensive a briefing commercial, legal, political, and scientific trends in biotechnology.

Thank you for your attention, and feel free to contact me at any time with your suggestions or requests for business connections.

Ryogen Receives Nine Human Gene Patents in 2012 for Total of 23-Patent…

Ryogen Portfolio of 23 Issued Patents Cover Genes Associated with Several Cancers, Diabetes, Obesity, Pancreatitis, Hepatitis, Lupus, Asthma, Hypertension and Alzheimer’s Disease

(PRWeb February 13, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10421030.htm